Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Cardiology Society Leaders Expand on Vision for New Medical Board

News Daily News

Cardiology Society Leaders Expand on Vision for New Medical Board

October 05, 2023

Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations

Presentation TVT 2022

Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations

Presenter: George Dangas

June 10, 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

April 05, 2022

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting

News Conference News ESC 2021

ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting

August 28, 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

March 08, 2021

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

November 17, 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

April 16, 2019

Should We Anticoagulate “All” Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presentation TCT 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas

September 22, 2018

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

November 30, 2017

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

Devices for the Right Heart (Tricuspid and Pulmonic Valves)

Presentation TCT 2016

Devices for the Right Heart (Tricuspid and Pulmonic Valves)

Presenter: Blase A. Carabello, George D. Dangas, Colin M. Barker

November 01, 2016

Transcatheter Mitral Valve Replacement

Presentation TCT 2016

Transcatheter Mitral Valve Replacement

Presenter: Blase A. Carabello, George D. Dangas, Howard C. Herrmann

November 01, 2016

Transcatheter Mitral Valve Repair: Results With Approved Devices (US and OUS)

Presentation TCT 2016

Transcatheter Mitral Valve Repair: Results With Approved Devices (US and OUS)

Presenter: Blase A. Carabello, George D. Dangas, Alec S. Vahanian

November 01, 2016

Future TAVR Devices and Adjunctive Therapies

Presentation TCT 2016

Future TAVR Devices and Adjunctive Therapies

Presenter: Blase A. Carabello, George D. Dangas

November 01, 2016

TAVR: Current Status of Devices and Indications

Presentation TCT 2016

TAVR: Current Status of Devices and Indications

Presenter: Blase A. Carabello, George D. Dangas, Vinod H. Thourani

November 01, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

September 13, 2016

News Daily News

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

September 13, 2016

ASD/VSD Technical Steps in Management

Presentation TCT 2014

ASD/VSD Technical Steps in Management

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab

September 16, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.